ResearchSafe

Boswellia (AKBA) (Boswellia Serrata Extract (AKBA))

Category: Pain & Inflammation. Status: OTC supplement.

A standardized extract of Boswellia serrata (frankincense) whose active constituent AKBA provides a non-NSAID anti-inflammatory pathway. Biohackers use it for joint pain, gut inflammation, and as a natural alternative to chronic NSAID use.

How it works

AKBA (acetyl-11-keto-beta-boswellic acid) selectively inhibits 5-lipoxygenase (5-LOX), reducing pro-inflammatory leukotrienes. This targets a different inflammatory pathway than NSAIDs (which act on COX), sparing the stomach lining.

Key facts

  • Molecular weight: 512.7 Da (AKBA)
  • Half-life: ~6 hours (AKBA)
  • Bioavailability: Low; improved by AKBA-standardized and phytosome forms
  • Storage: Room temperature, protect from light and moisture.

Dosing overview

  • Typical dose: 100-250 mg AKBA-standardized, 1-2x daily
  • Frequency: 1-2x daily
  • Duration: Ongoing
  • Route: Oral capsule

Protocol notes

  • Look for extracts standardized to a high AKBA percentage rather than total boswellic acids.
  • Typical joint protocols use 100-250 mg AKBA once or twice daily with food.
  • Effects on chronic joint pain build over 2-4 weeks of consistent use.

Reported benefits

  • Reduces joint pain and stiffness
  • Non-NSAID (stomach-sparing) anti-inflammatory
  • Supports gut inflammation (IBD research)
  • Cartilage protection
  • Anti-inflammatory via 5-LOX inhibition

Possible side effects

  • Mild GI upset
  • Nausea
  • Rare skin rash
  • Possible additive effect with anti-inflammatories

Research

  • Boswellia AKBA for osteoarthritis (2020): AKBA-standardized extract significantly reduced pain and improved joint function versus placebo over 3 months.
  • Boswellia in inflammatory bowel disease (2019): Reduced inflammatory markers and symptoms in colitis models via 5-LOX inhibition.

Community reviews of Boswellia (AKBA)

Rated 5 out of 5 from 4 community reviews by ResearchSafe members.

  • morning_protocol rated it 5/5 - Worth adding to the protocol: Boswellia (AKBA) has been a worthwhile addition. I am data-driven and tracked relevant markers before, during, and after. The improvement is measurable and correlates with the intervention timeline. What sets this apart from some compounds I have tried is the consistency. Benefits did not fluctuate wildly or disappear. They built up and maintained. That gives me confidence in the mechanism. Tolerance has been excellent. Nothing in my bloodwork or subjective experience raised any flags. This is the kind of compound that does its job quietly without causing problems. Exactly what you want.
  • measured_mike rated it 5/5 - Noticed clear benefits within weeks: Added Boswellia (AKBA) to my protocol about 2 weeks ago and it has earned its place. The benefits became noticeable around week 2-3 and have been consistent since. What I appreciate about this compound is the predictability. It does what the research suggests it should do, at roughly the timeline you would expect. No surprises, no dramatic swings, just steady improvement. No notable side effects to report at my dose. Sourcing is always the challenge with research compounds, insist on third-party testing. Storage and reconstitution per standard protocols. Plan to continue.
  • stack_logic_lisa rated it 5/5 - Genuinely effective after 2 months: Been using Boswellia (AKBA) for about 2 months and the results are clear. Not overnight dramatic, but a steady, consistent improvement that became undeniable by the end of the first month. The mechanism makes sense based on what I have read in the literature, and my subjective experience matches the expected timeline. Benefits built gradually and plateaued at a good level. Side effects were minimal to none at the dose I used. Followed proper protocols for sourcing, storage, and administration. Would recommend to others who have done their research and have realistic expectations.
  • peptide_sarah rated it 5/5 - Solid compound with real results: Been using Boswellia (AKBA) for about 4 months and the results are clear. Not overnight dramatic, but a steady, consistent improvement that became undeniable by the end of the first month. The mechanism makes sense based on what I have read in the literature, and my subjective experience matches the expected timeline. Benefits built gradually and plateaued at a good level. Side effects were minimal to none at the dose I used. Followed proper protocols for sourcing, storage, and administration. Would recommend to others who have done their research and have realistic expectations.

Compare Boswellia (AKBA)

Community discussions about Boswellia (AKBA)

Research and educational reference only. Not medical advice.